Eliquis Tablet, Film Coated
Product Images NDC 71610-662

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Eliquis (NDC 71610-662). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 5 mg (71610 0662 09)

Apixaban (Eliquis) is a prescription medication available in the form of tablets with a dosage of 5mg per tablet. The package size consists of 9000 tablets. The drug code (DC#) for this medication is 71610-066209, and there is additional text that is not readable.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Apixaban Chemical Structure (Apixaban Struct)

FDA Label Image

Aristotle Forest Plot (Eliquis Clin Forest Fig5)

FDA Label Image

Aristotle Major Bleeding Forest Plot (Eliquis Forest Fig1)

The given text is a table of various subgroups of patients and their corresponding results for apixaban and warfarin in terms of hazard ratio, number of events, number of patients, and percentage per year. The subgroups include patients with different ages, weights, prior stroke or TIA, diabetes status, geographic region, and other characteristics. The table also shows the reliability of apixaban compared to warfarin for each subgroup.*

FDA Label Image

Aristotle Kaplan-meier Curve (Eliquis Km Fig4)

FDA Label Image

Effect Of Coadministered Drugs On Pharmacokinetics Of Apixaban (Eliquis Pkplot Drugs Fig2)

This appears to be a table or chart displaying the results of a study on drug interactions. The drugs involved are inhibitors or inducers of P-gp and Strong CYP3A4. The table displays fold change and 90% confidence interval data for the interacting drug's PK (pharmacokinetics) when combined with each of the listed drugs. The results are presented in terms of AUC (area under the curve). The drugs listed include ketoconazole, glarithromycin, diltiazem, naproxen, and rifampin.*

FDA Label Image

O:\e-submissions\pbo\products\eliquis 202155\08. Pas Esrd Dosing\01. Orig Submission\source\eliquis-pkplot-pop-fig3.jpg (Eliquis Pkplot Pop Fig3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.